Skip to content
    Real-World Studies

    Conditional Survival and Racial Disparities in Oral Cavity Squamous Cell Carcinoma

    Wang et alEuropean Archives of Oto-Rhino-Laryngology

    Conditional Survival and Racial Disparities in Oral Cavity Squamous Cell Carcinoma
    In a population-based retrospective study evaluating racial disparities in conditional survival (CS) among patients with oral cavity squamous cell carcinoma (OSCC), researchers analyzed 24,632 individuals diagnosed between 2004 and 2015 using the Surveillance, Epidemiology, and End Results (SEER) database. Five-year cancer-specific CS was calculated via the Kaplan–Meier method, and multivariable time-varying Cox regression was utilized to assess 5-year mortality hazard ratios (HRs) by race, adjusting for age, socioeconomic demographics, tumor grade, stage, subsite, and treatment modality.
    The cohort comprised 85.6% White, 6.7% Black, and 7.7% Asian/Pacific Islander (API) patients. At baseline, marked survival disparities were observed: initial 5-year CS was 43.4% in Black patients compared to 62.1% in White and 63.0% in API patients. However, survival differences narrowed over time, reaching 84.3% in Black, 87.7% in White, and 89.3% in API patients by post-treatment year 5.
    Multivariable analysis indicated that Black patients experienced elevated mortality risk in early follow-up (Year 1 HR: 1.21, 95% CI: 1.10–1.33, P < 0.001), but this excess risk was no longer statistically significant among long-term survivors (Year 5 HR: 1.05, 95% CI: 0.84–1.32, P = 0.642, with 90 events among 553 Black patients at risk). API patients exhibited outcomes comparable to White patients across all time points. The authors concluded that racial survival disparities in OSCC follow a convergence trajectory, with excess mortality risk concentrated in the first three post-treatment years, implicating early-phase factors as drivers of disparity.

    Key Takeaways

    • Black patients with oral cavity squamous cell carcinoma had an initial 5-year conditional survival rate of 43.4% compared with 62.1% for White and 63.0% for Asian/Pacific Islander patients, which narrowed to 84.3%, 87.7%, and 89.3%, respectively, by post-treatment year 5.
    • Black patients faced an elevated mortality risk at year 1 post-treatment (adjusted HR: 1.21, 95% CI: 1.10–1.33, P < 0.001), which attenuated and was no longer statistically significant by year 5 (HR: 1.05, 95% CI: 0.84–1.32, P = 0.642).
    Read the original sourceEuropean Archives of Oto-Rhino-Laryngology